Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipyretics and Prevenar 13 Immunogenicity in Infants
NCT01392378Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2011
- Primary completion
- Jan 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Aug 2011; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01392378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392378.